Huma’s ‘healthtech’ platform monitors patients remotely via an app. Patients with cardiac failure, diabetes, musculoskeletal issues, rare diseases and more, use an app to remotely relay their health information to clinicians and researchers. Huma claims that its platform can lower mortality rates, almost double clinical capacity and cut hospital readmission rates by a third. It supports a network of 27m patients and works with over 3,000 hospitals, clinics, academic institutions and pharmaceutical firms such as AstraZeneca, J&J and Bayer. Founded in 2011 by Dan Vahdat and Rich Khatib, Huma has raised $250m to date.